EXHIBIT 1
JOINT FILING AGREEMENT
In accordance with Rule 13d−1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of The Medicines Company and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 30th day of May, 2019.
SARISSA CAPITAL MANAGEMENT LP | |
By: | /s/ Mark DiPaolo Name: Mark DiPaolo Title: Senior Partner, General Counsel |
SARISSA CAPITAL OFFSHORE MASTER FUND LP | |
By: Sarissa Capital Offshore Fund GP LLC, its general partner | |
By: | /s/ Mark DiPaolo Name: Mark DiPaolo Title: Authorized Person |
SARISSA CAPITAL CATAPULT FUND LLC | |
By: Sarissa Capital Management LP, its managing member | |
By: | /s/ Mark DiPaolo Name: Mark DiPaolo Title: Senior Partner, General Counsel |
SARISSA CAPITAL HAWKEYE FUND LP | |
By: Sarissa Capital Fund GP LP, its general partner | |
By: | /s/ Mark DiPaolo Name: Mark DiPaolo Title: Authorized Person |
SARISSA CAPITAL ATHENA FUND LTD | |
By: | /s/ Alexander J. Denner, Ph.D Name: Alexander J. Denner, Ph.D. Title: Director |
/s/Alexander J. Denner, Ph.D.__________________
Alexander J. Denner, Ph.D.
Alexander J. Denner, Ph.D.